Acetazolamide/Dronabinol
乙酰唑胺/屈大麻酚
Report date: 2023/11/28 20:05:47
Base Information
Drug NameAcetazolamide/Dronabinol
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes AcetazolamideDronabinol
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesIncannex Healthcare Ltd
China Registration ClassN/A
Develop Information
Active CompaniesIncannex Healthcare Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A